Securities Purchase
Agreement
The undersigned
investor (the “ Investor ”) hereby confirms
Investor’s agreement with Arcadia Resources, Inc.
(“Arcadia” or the “Company”) as
follows:
1. This Securities Purchase Agreement is made as of
the date set forth below between the Company and the
Investor.
2. The
Company has authorized the sale and issuance of 4,999,999 shares
(the “ Shares ”) of the common stock of the
Company, $0.001 par value per share (the “ Common
Stock ”), to the Investor in a private placement (the
“ Offering ”).
3. The
Company and the Investor agree that the Investor will purchase from
the Company and the Company will issue and sell to the Investor
4,999,999 Shares at a purchase price of $2.00 per Share, for an
aggregate purchase price of $9,999,998.00 (the “ Purchase
Price ”), subject to the Terms and Conditions for
Purchase of Shares attached hereto as Annex I and incorporated
herein by reference as if fully set forth herein. Unless otherwise
requested by the Investor in Exhibit “A”, certificates
representing the Shares purchased by the Investor will be
registered in the Investor’s name and address as set forth
below.
4. The
Investor represents that, except as set forth below, (a) it
has had no position, office or other material relationship within
the past three (3) years with the Company or its affiliates,
(b) neither it, nor any group of which it is a member or to
which it is related, beneficially owns (including the right to
acquire or vote) any securities of the Company, (c) neither it, nor
any group of which it is a member or to which it is related,
acquired, directly or indirectly, any securities of the Company in
a certain private placement transaction that closed on
November 30, 2006, and (d) it has no direct or indirect
affiliation or association with any National Association of
Securities Dealers, Inc. (“ NASD ”) member.
Exceptions:
(If no exceptions, write
“none.” If left blank, response will be deemed to be
“none.”)
Please confirm
that the foregoing correctly sets forth the agreement between us by
signing in the space provided below for that purpose.
|
|
|
|
|
|
|
|
|
|
|
Dated as of:
December 28, 2006
|
|
|
|
|
|
|
|
|
|
|
|
Capital
Research and Management Company
|
|
|
|
on behalf of
SMALLCAP World Fund, Inc. and
|
|
|
|
American Funds
Insurance Series, Global Small
|
|
|
|
Capitalization
Fund
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Catherine
M. Ward
|
|
|
|
|
Name:
|
Catherine M.
Ward
|
|
|
|
|
Title:
|
Sr. Vice
President
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Address:
|
|
333 S. Hope
St.
|
|
|
|
|
|
|
|
Los Angeles,
CA
|
|
|
|
|
|
|
|
90071
|
|
|
|
|
|
|
|
|
|
|
|
/s/ John E.
Elliott, II
|
|
|
|
|
|
|
|
|
|
|
|
Name: John E.
Elliott, II
|
|
|
|
|
|
Title: Chairman
and CEO
|
|
|
[SECURITIES PURCHASE AGREEMENT
SIGNATURE PAGE]
2
Terms
and Conditions for Purchase of Shares
1. Agreement to Sell and Purchase the Shares; Subscription
Date.
1.1 Purchase and Sale . At the Closing (as defined in
Section 2), the Company will sell to the Investor, and the
Investor will purchase from the Company, upon the terms and subject
to the conditions set forth herein, and at the Purchase Price, the
number of Shares described in paragraph 3 of the Securities
Purchase Agreement attached hereto (collectively with this Annex I
and the other exhibits attached hereto, this “
Agreement ”). The Registration Rights Agreement and
the Securities Purchase Agreement executed by the Investor are
sometimes collectively referred to herein as the “
Agreements .” The Investor must execute and deliver
the Securities Purchase Agreement and the Registration Rights
Agreement and must complete the Stock Certificate Questionnaire (in
the form attached as Exhibit “A” hereto) and the
Investor Questionnaire (in the form attached as Exhibit
“B” hereto) in order to purchase Shares.
1.2 Placement Agent Fee . The Investor acknowledges that the
Company intends to pay to The Shemano Group, Inc. (in its capacity
as placement agent for the Shares, the “ Placement
Agent ”) a fee in respect of the sale of Shares to the
Investor from the proceeds of the Offering.
2. Delivery of the Shares at Closing. The completion of
the purchase and sale of the Shares (the “ Closing
”) shall occur on a date specified by the Company and the
Placement Agent that is anticipated to be December 28, 2006
(the “ Closing Date ”), but which date shall not
be later than December 29, 2006 (the “ Outside
Date ”), and of which the Investor will be notified in
advance by the Placement Agent. At the Closing or upon AMEX listing
approval of the Shares, whichever is later, the Company shall
deliver to the Investor one or more stock certificates representing
the number of Shares set forth in paragraph 3 of the Stock Purchase
Agreement, each such certificate to be registered in the name of
the Investor or, if so indicated on the Stock Certificate
Questionnaire, in the name of a nominee designated by the Investor.
In exchange for the delivery of the subscription agreements, the
Investor shall deliver at Closing the Purchase Price directly to
the Company by wire transfer of immediately available funds
pursuant to written instructions. On the Closing Date, the Company
shall cause counsel to the Company to deliver to the Investors a
legal opinion, dated the Closing Date, in the form attached hereto
as Exhibit “C” (the “ Legal Opinion
”).
The
Company’s obligation to issue and sell the Shares to the
Investor shall be subject to the following conditions, any one or
more of which may be waived by the Company: (a) prior receipt
by the Company of an executed copy of this Securities Purchase
Agreement; (b) the accuracy of the representations and
warranties made by the Investor in this Agreement and the
fulfillment of the obligations of the Investor to be fulfilled by
it under this Agreement on or prior to the Closing; (c) the
Company is satisfied that the issuance of the Securities will not
be in violation of applicable AMEX listing qualification rules; and
(d) the absence of any order, writ, injunction, judgment or
decree that questions the validity of the Agreements or the right
of the Company or the Investor to enter into such Agreements or to
consummate the transactions contemplated hereby and
thereby.
The
Investor’s obligation to purchase the Shares shall be subject
to the following conditions, any one or more of which may be waived
by the Investor: (a) the delivery of the Legal Opinion to the
Investor by counsel to the Company; (b) the accuracy of the
representations and warranties made by the Company in this
Agreement on the Closing Date; (c) the execution and delivery
by the Company of the Registration Rights Agreement; and
(d) the absence of any order, writ, injunction, judgment or
decree that questions the validity of the Agreements or the right
of the Company or the Investor to enter into such Agreements or to
consummate the transactions contemplated hereby and
thereby.
1
In the event that
the Closing does not occur on or before the Outside Date as a
result of the Company’s failure to satisfy any of the
conditions set forth above (and such condition has not been waived
by the Investor), the Company shall return any and all funds paid
hereunder to the Investor no later than one Business Day following
the Outside Date and the Investors shall have no further
obligations hereunder. For purposes of this Agreement, “
Business Day ” shall mean any day other than a
Saturday, Sunday or other day on which the New York Stock Exchange
is permitted or required by law to close.
3. Representations, Warranties and Covenants of the
Company. Except as otherwise described in the Company’s
Annual Report on Form 10-K for the year ended March 31, 2006
(and any amendments thereto filed at least two (2) Business
Days prior to the Closing Date), the Company’s S-1
Registration Statement effective July 18, 2006, the
Company’s most recent Quarterly Report on Form 10-Q for the
quarter ended September 30, 2006, the Company’s Proxy
Statement for its 2006 Annual Meeting of Shareholders, and any of
the Company’s Current Reports on Form 8-K filed since
March 31, 2006 (and any amendments thereto filed at least two
(2) Business Days prior to the Closing Date) (all
collectively, the “ SEC Reports ”), the Company
hereby represents and warrants to, and covenants with, the Investor
as of the date hereof and the Closing Date, as follows:
3.1 Organization. The Company is duly incorporated and
validly existing in good standing under the laws of the State of
Nevada. The Company has full power and authority to own, operate
and occupy its properties and to conduct its business as presently
conducted and is registered or qualified to do business and in good
standing in each jurisdiction in which it owns property or
transacts business and where the failure to be so qualified would
have a material adverse effect upon the Company and its
subsidiaries as a whole or the business, financial condition,
properties, operations or assets of the Company and its
subsidiaries as a whole or the Company’s ability to perform
its obligations under the Agreements in all material respects
(“ Material Adverse Effect ”), and no proceeding
has been instituted in any such jurisdiction revoking, limiting or
curtailing, or seeking to revoke, limit or curtail, such power and
authority or qualification.
3.2 Due Authorization. The Agreements have been validly
executed and delivered by the Company and constitute legal, valid
and binding agreements of the Company enforceable against the
Company in accordance with their terms, except to the extent
(i) rights to indemnity and contribution may be limited by
state or federal securities laws or the public policy underlying
such laws, (ii) such enforceability may be limited by
applicable bankruptcy, insolvency, reorganization, moratorium or
similar laws affecting creditors’ and contracting
parties’ rights generally and (iii) such enforceability
may be subject to general principles of equity (regardless of
whether such enforceability is considered in a proceeding in equity
or at law).
3.3 No Conflict or Default. The execution and delivery of
the Agreements, the issuance and sale of the Shares to be sold by
the Company under the Agreements, the fulfillment of the terms of
the Agreements and the consummation of the transactions
contemplated thereby will not: (A) result in a conflict with
or constitute a material violation of, or material default (with
the passage of time or otherwise) under, (i) any bond,
debenture, note, loan agreement or other evidence of indebtedness,
or any material lease, or contract to which the Company is a party
or by which the Company or their respective properties are bound,
(ii) the Certificate of Incorporation, by-laws or other
organizational documents of the Company, as amended, or
(iii) any law, administrative regulation, or existing order of
any court or governmental agency, or other authority binding upon
the Company or the Company’s respective properties; or,
(B) result in the creation or imposition of any lien,
encumbrance, claim, or
2
security
interest upon any of the material assets of the Company or an
acceleration of indebtedness pursuant to any obligation, agreement
or condition contained in any material bond, debenture, note or any
other evidence of indebtedness or any material indenture, mortgage,
deed of trust or any other agreement or instrument to which the
Company is a party or by which it is bound or to which any of the
property or assets of the Company is subject, that would have a
Material Adverse Effect. Except for AMEX listing approval of the
Shares, no consent, approval, authorization or other order of, or
registration, qualification or filing with, any regulatory body,
administrative agency, or other governmental body is required for
the execution and delivery of the Agreements by the Company and the
valid issuance or sale of the Shares by the Company pursuant to the
Agreements, other than such as have been made or obtained, and
except for any filings required to be made under federal or state
securities laws.
3.4
Capitalization. The outstanding capital stock of the Company is
as described in the Company’s Quarterly Report on Form 10-Q
for the three month period ending September 30, 2006. Except
as described in the SEC Reports, since September 30, 2006, the
Company has not issued any capital stock, other than pursuant to
the purchase of shares under the Company’s employee stock
option plan and the exercise of outstanding warrants or stock
options. The Shares to be sold pursuant to the Agreements have been
duly authorized, and when issued and paid for in accordance with
the terms of the Agreements, will be duly and validly issued, fully
paid and nonassessable, subject to no lien, claim or encumbrance
(except for any such lien, claim or encumbrance created, directly
or indirectly, by the Investor). The outstanding shares of capital
stock of the Company have been duly and validly issued and are
fully paid and nonassessable, have been issued in compliance with
the registration requirements of federal and state securities laws,
and were not issued in violation of any preemptive rights or
similar rights to subscribe for or purchase securities. The Company
owns one hundred percent of all of the outstanding capital stock of
each of its subsidiaries, free and clear of all liens, claims and
encumbrances, except for Care Clinic, Inc. as to which the Company
owns 85% of the outstanding capital stock. There are not
(i) any outstanding preemptive rights except as described in
the SEC Reports, or (ii) any rights, warrants or options to
acquire, or instruments convertible into or exchangeable for, any
unissued shares of capital stock or other equity interest in the
Company not disclosed in the SEC Reports, or (iii) any contract or
agreement to which the Company is a party that would provide for
the issuance or sale of any capital stock of the Company, any such
convertible or exchangeable securities or any such rights, warrants
or options not disclosed in the SEC Reports. There are no
shareholders agreements, voting agreements or other similar
agreements with respect to the Common Stock to which the Company is
a party, other than as described in SEC Reports.
3.5 Legal
Proceedings. There is no material legal or governmental
proceeding pending, or to the actual knowledge of the Company,
threatened, to which the Company is a party or of which the
business or property of the Company is subject that is required to
be disclosed and that is not so disclosed in the SEC Reports. Other
than the information disclosed in the SEC Reports, the Company is
not subject to any injunction, judgment, decree or order of any
court, regulatory body, administrative agency or other government
body.
3.6 No
Violations. The Company is not in violation of its Certificate
of Incorporation, bylaws or other organizational documents, as
amended, that is reasonably likely to have a Material Adverse
Effect. The Company is not in violation of any law, administrative
regulation, ordinance or order of any court or governmental agency,
arbitration panel or authority applicable to the Company, which
violation, individually or in the aggregate, is reasonably likely
to have a Material Adverse Effect. The Company is not in default
(and there exists no condition which, with the passage of time or
otherwise, would constitute a default) in the performance of any
bond, debenture, note or any other evidence of indebtedness or any
indenture, mortgage, deed of trust or any other material agreement
or instrument to which the Company is a party or by which the
Company is bound, which such default is reasonably likely to have a
Material Adverse Effect upon the Company.
3
3.7
Governmental Permits, Etc. The Company has all necessary
franchises, licenses, certificates and other authorizations from
any foreign, federal, state or local government or governmental
agency, department or body that are currently necessary for the
operation of the business of the Company as currently conducted,
except where the failure to currently possess such franchises,
licenses, certificates and other authorizations is not reasonably
likely to have a Material Adverse Effect.
3.8
Intellectual Property.
(a) Except for matters which are not reasonably likely to
have a Material Adverse Effect, (i) each of the Company has
ownership of, or a license or other legal right to use, all
patents, copyrights, trade secrets, trademarks, customer lists,
designs, manufacturing or other processes, computer software,
systems, data compilation, research results or other proprietary
rights used in the business of the Company (collectively, “
Intellectual Property ”) and (ii) all of the
Intellectual Property owned by the Company consisting of patents,
registered trademarks and registered copyrights have been duly
registered in, filed in or issued by the United States Patent and
Trademark Office, the United States Register of Copyrights or the
corresponding offices of other jurisdictions and have been
maintained and renewed in accordance with all applicable provisions
of law and administrative regulations in the United States and/or
such other jurisdictions.
(b) Except for matters which are not reasonably likely to
have a Material Adverse Effect, all material licenses or other
material agreements under which (i) the Company employs rights
in Intellectual Property, or (ii) the Company has granted
rights to others in Intellectual Property owned or licensed by the
Company are in full force and effect, and there is no default by
the Company with respect thereto.
(c) The Company believes that it has taken all steps
reasonably required in accordance with sound business practice and
business judgment to establish and preserve the ownership of the
Company’s material Intellectual Property.
(d) Except for matters which are not reasonably likely to
have a Material Adverse Effect, to the actual knowledge of the
Company, (i) the present business, activities and products of
the Company do not infringe any intellectual property of any other
person; (ii) neither the Company is making unauthorized use of
any confidential information or trade secrets of any person; and
(iii) the activities of any of the employees of the Company,
acting on behalf of the Company, do not materially violate any
agreements or arrangements related to confidential information or
trade secrets of third parties.
(e) Except for matters which are not reasonably likely to
have a Material Adverse Effect, and except as disclosed in the SEC
Reports, no proceedings are pending, or to the knowledge of the
Company, threatened, which challenge the rights of the Company to
the use the Company’s Intellectual Property.
3.9 Financial
Statements. The financial statements of the Company and the
related notes contained in the SEC Reports present fairly in all
material respects the financial position of the Company as of the
dates therein indicated, and the results of its operations, cash
flows and the changes in shareholders’ equity for the periods
therein specified, subject, in the case of unaudited financial
statements for interim periods, to normal year-end audit
adjustments. Such financial statements (including the related
notes) have been prepared in accordance with generally accepted
accounting principles applied on a consistent basis at the times
and throughout the periods therein specified, except that unaudited
financial statements may not contain all footnotes required by
generally accepted accounting principles.
4
3.10 No
Material Adverse Change. Except as disclosed in the SEC Reports
or in any press releases issued by the Company at least two
(2) Business Days prior to the Closing Date, there has not
been (i) an event, circumstance or change that has had or is
reasonably likely to have a Material Adverse Effect upon the
Company, (ii) any obligation incurred by the Company that is
material to the Company, (iii) any dividend or distribution of
any kind declared, paid or made on the capital stock of the
Company, or (iv) any loss or damage (whether or not insured)
to the physical property of the Company which has had a Material
Adverse Effect.
3.11 AMEX
Compliance. The Company’s Common Stock is registered
pursuant to Section 12(b) of the Securities Exchange Act of 1934,
as amended (the “ Exchange Act ”), and is listed
on the American Stock Exchange (“ AMEX ”), and
the Company has taken no action intended to, or which to its actual
knowledge could have the effect of, terminating the registration of
the Common Stock under the Exchange Act or delisting the Common
Stock from AMEX.
3.12 Reporting
Status. The Company has timely made all filings required under
the Exchange Act during the twelve (12) months preceding the
date of this Agreement, and all of those documents complied in all
material respects with the SEC’s requirements as of their
respective filing dates, and the information contained therein as
of the respective dates thereof did not contain an untrue statement
of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein in light
of the circumstances under which they were made not misleading. The
Company is currently eligible to register the resale of Common
Stock by the Investors pursuant to a registration statement on Form
S-3 under the Securities Act or on such other form as may be
available to the Company (the “ Registration Statement
”).
3.13 No
Manipulation; Disclosure of Information. The Company has not
taken and will not take any action designed to or that might
reasonably be expected to cause or result in an unlawful
manipulation of the price of the Common Stock to facilitate the
sale or resale of the Shares. The Company has not disclosed any
material non-public information to the Investors.
3.14
Accountants. BDO Seidman, LLP, who expressed their opinion with
respect t
|